维普中文期刊产品整合服务
655篇 您的检索式:作者名="Starling"
    题名 作者 年代 出处 被引量
1Colorectal cancer显示文摘David Cunningham Wendy Atkin Heinz-Josef Lenz Henry T Lynch Bruce Minsky Bernard Nordlinger Naureen Starling 2010The Lancet2010,,9719:3
2Capecitabine and oxaliplatin for advanced esophagogastric cancer显示文摘Cunningham D Starling N Rao S the New England Journal of Medicine0,,:3
3Colorectal cancer显示文摘David Cunningham Wendy Atkin Heinz-Josef Lenz Henry T Lynch Bruce Minsky Bernard Nordlinger Naureen Starling 2010The Lancet2010,,9719:2
4Colorectal cancer显示文摘David Cunningham Wendy Atkin Heinz-Josef Lenz Henry T Lynch Bruce Minsky Bernard Nordlinger Naureen Starling 2010The Lancet . 2010 (9719)2010,,9719:2
5Inhibitors of HMG-Coa reductase sensitize human smooth muscle ceils to Fas-ligand and cytokine-induced cell death 显示文摘Knapp AC Huang J Starling G 2000Atherosclerosis2000,152,1:1
6Psychopathology in female juvenile offenders显示文摘Dixon A Howie P Starling J 2004J Child Psychol Psychiatry2004,45,6:1
7Effect of ne- siritide in patients with acute deeompensated heart failure显示文摘O'Connor CM Starling RC Hernandez AF 2011N Engl J Med2011,365,1:1
8Capecitabine and oxaliplatin for advanced esophagogastric cancer显示文摘Cunningham D Starling N Rao S 2008N Engl J Med2008,358,1:1
9Alternative techniques to reduce warm isehemia time in laparoscopie partial nephrectomy 显示文摘CARLOS A S TOBIAS-MACHADO M STARLING E S 2013Int Braz J Urol2013,39,1:1
10Effect of nesiritide in patients with acute decompensated heart failure显示文摘O'Connor CM Starling RC Hernandez AF 0,,01:1
11Capecitabine and oxaliplatin for advanced esophagogastric cancer显示文摘CUNNINGHAM D STARLING N RAO S 2008N Engl JMed2008,358,1:1
12Randomized multicenter phase Ⅲ study comparing capecitabine with fluorouracil and oxaliplatin cisplatin in patients with advanced oesophagegastric cancer:The REAL 2 trial显示文摘Cunningham D Rao S Starling N 0,,18:1
13Benign mechanical obstruction of the common hepatic duct (Mirizzi syndrome)显示文摘Starling JR Matallana RH 1980Surgery1980,88,5:1
14Superantigen-driven,CD8 + T cell-mediated down-regulation: CD95 ( Fas ) -dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells 显示文摘Stohl W Lynch DH Starling GC 1998J Immunol1998,161,32:1
15Preoperative risk factors formortality after biventricular assist device implantation显示文摘Zahr F Ootaki Y Starling RC 2008J CardFail2008,14,10:1
16Mechanisms of disease:Calpains and disease显示文摘Zatz M Starling A 2005New Eng J Med2005,352,23:1
17Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy 显示文摘McNamara DM Holubkov R Starling RC 2001Circulation2001,103,18:1
18Phase Ⅰ study of epirubicin, cisp-latin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer显示文摘Rao S Starling N Cunningham D 2008Br J Cancer2008,99,6:1
19Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979显示文摘 Cao J Starling JJ 2003Int J Cancer2003,103,1:1
20Preliminary observations withventricular remodeling surgery for refractory congestive heart failure显示文摘Starling RC Young JB Scalia GM 1997J Am CollCardiol1997,29,:1
返回顶部 每页显示:
共33页 首页 上一页 第1页 下一页 末页 /33 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费